LAS-R CERULOPLASMIN TEST— 510(k) K771795

Name: FDA 510(k) clearance K771795
Creator: U.S. Food and Drug Administration
Published: 1977-11-14

Substantially Equivalent

Hyland Therapeutic Div., Travenol Laboratories

FDA 510(k) clearance K771795 for LAS-R CERULOPLASMIN TEST, Substantially Equivalent on 1977-11-14. Applicant: Hyland Therapeutic Div., Travenol Laboratories. Device class: 2.

Clearance details

Applicant: Hyland Therapeutic Div., Travenol Laboratories
Product code: Code DDB
Device class: Class 2
Regulation: 21 CFR 866.5210
Advisory panel: Immunology
Date received: 1977-09-23
Decision date: 1977-11-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DDB

view all

K161508 — Ceruloplasmin2017-01-09
K122965 — HUMAN CAERULOPLASMIN KIT2013-06-03
K053074 — N ANTISERA TO HUMAN CERULOPLASMIN2006-03-16
K964762 — IMMAGE IMMUNOCHEMISTRY SYSTEM CERULOPLASMIN (CER) REAGENT1997-04-25
K913668 — CAERULOPLASMIN IMMUNOLOGICAL NL TEST KIT1991-12-20

More clearances from Hyland Therapeutic Div., Travenol Laboratories

view all

K820835 — ALUMINA SILICA-ACTIVATED PARTIAL THROM1982-04-26
K820192 — HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM1982-03-11
K812220 — NEPHELOMETRIC SOLID TURBIDITY STANDARD1981-08-18
K810078 — Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S1981-02-02
K810077 — OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.1981-01-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.